Novartis Makes $3bn Bet On Synnovation’s PI3Kα Inhibitor SNV4818

 
• By Sushmita Panda
  
Novartis logo on building
Novartis (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business